Inspire Medical Systems, Inc. Cash and Equivalents

Quick Answer

Inspire Medical Systems, Inc. reported Cash and Equivalents of $104.81 million for fiscal year 2025.

Inspire Medical Systems, Inc. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $104.81M -30.2%
2024 $150.15M -19.1%
2023 $185.54M -58.0%
2022 $441.59M +105.9%
2021 $214.47M +12.6%
2020 $190.52M +733.4%
2019 $22.86M -76.5%
2018 $97.29M +986.4%
2017 $8.96M +34.0%
2016 $6.68M -44.9%
2015 $12.13M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $112.84M -23.5% +5.5%
June 30, 2025 $106.93M -43.1% +98.4%
March 31, 2025 $53.88M -69.3% -64.1%
December 31, 2024 $150.15M -19.1% +1.8%
September 30, 2024 $147.51M -55.3% -21.6%
June 30, 2024 $188.03M -59.7% +7.2%
March 31, 2024 $175.42M -60.3% -5.5%
December 31, 2023 $185.54M -58.0% -43.8%
  • Inspire Medical Systems, Inc. showed a decrease of -30.2% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2015–2025 period, Inspire Medical Systems, Inc.’s cash and equivalents has grown by 764.4% (from $12.13 million to $104.81 million).
  • The most recent figure is from Inspire Medical Systems, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment